Bristol Myers Squibb wins fifth US approval for CAR T cell therapy Breyanzi
The FDA’s latest authorisation makes it the most widely approved…
The FDA’s latest authorisation makes it the most widely approved of any CD19-directed CAR T therapy in cancer.





